A conversation with Novartis Chief Digital Officer Bertrand Bodson

Novartis researchers aim to preserve kidney function – and quality of life – for patients.

Researchers focus on reversing the scarring that’s common to liver diseases.

Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

When Laurie Brunner found a lump in her breast just before Thanksgiving in 2018, it was the beginning of one of the most difficult periods of her life. Although treatment put her cancer into remission, she found herself dealing with an emotional toll that affects many survivors of early-stage breast cancer: the fear of it coming back.

Photos: Brent Stirton, Getty Images for Novartis

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.